Problems in the Diagnosis and Treatment of Invasive Fungal Infections: Recent Advances in Their Management, ESCMID Postgraduate Education Course

2 - 3 March 2012, Athens, Greece

Organisers
  • Hellenic Society of Medical Mycology (HSMM)
  • ESCMID Fungal Infection Study Group (EFISG)
  • 4th Department of Internal Medicine, National Kapodistrian University of Athens
Course Objectives

The course will provide an update on epidemiology, diagnosis and treatment of invasive fungal infections. It puts emphasis on host characteristics in various groups, such as patients with neutropenia, stem cell transplantation, solid organ transplantation, HIV, iron overload, trauma, etc.

 

Course Venue

Royal Olympic Hotel
28-34 Ath. Diakou
Athens 117 43
Greece

Website

Target Audience

Up to 120 infectious disease specialists, clinical microbiologists, mycologists, hematologists, intensivists and PhD students.

Contact Person

Prof George L. Petrikkos, Athens, GR

Phone + 30-210-583 1989
Fax + 30-210-532 6446



Administrative Secretariat

Mr Sotiris Iliadis
The MASTERMIND Group
26,Marathonomahon   st. 15125
Maroussi, Greece

Tel +30 210 6827405 / +30 210 6839690-1
Fax +30 2106827409

Course Programme


Presentations are availabe in the ESCMID Online Lecture Library.

Friday, 2 March 2012

14.00 – 15.30 Changing epidemiology of invasive fungal infections

  • Candida
  • Aspergillus
  • Emerging pathogens

16.00 – 18.00 Problems and progress in the diagnosis of IFIs

  • When should the clinician suspect the presence of IFI?
  • Early diagnosis with the aid of serological markers
  • Molecular methods in the diagnosis of IFIs: How far have we advanced?
  • Definitive diagnosis of invasive fungal infections: an elusive target

18.00 –18.45 Correlation of in vitro susceptibility to clinical outcome

Saturday, 3 March 2012

09.00 –10.30 Problems in treatment arising from the fungus

  • Treatment of IFIs due to resistant strains of Aspergillus
  • Treatment of IFIs due to Scedosporium and Fusarium species
  • Treatment of IFIs due to Cryptococcus
  • Treatment of IFIs due to Mucorales

10.30 –12.00 Difficult to treat IFIs

  • Fungal endocarditis
  • Fungal infections of the CNS
  • Osteoarticular fungal infections

12.30 –14.00 Problems in treatment due to altered PK/PD

  • Azoles: Are we under-treating our patient?
  • Dosing of antifungals in patients with renal or hepatic failure
  • PK/PD of antifungals in neonates and infants

15.00 –16.30 Recent advances in the treatment of IFIs

  • Activities of newer antifungals against Candida biofilms
  • Combination of antifungals: an update
  • Newer antifungals: what’s in the pipeline

16.30 –18.00 Patients at high risk of invasive fungal infections: when and how to treat

  • Candida prophylaxis in critically ill patients
  • Aspergillus sp. in bronchial secretions of ICU patients: when should we treat?
  • Febrile neutropenia: pre-emptive or targeted treatment?

18.00 – 19.00 Interactive case presentations
19.00 Closing remarks

Course Faculty
  • Anastasia Antoniadou, Athens, Greece
  • Oliver Cornely, Cologne, Germany
  • Manuel Cuenca-Estrella, Madrid, Spain
  • George Daikos, Athens, Greece
  • Miranda Drogari-Apiranthitou, Athens, Greece
  • Andreas Groll, Muenster, Germany
  • Lene Klingspor, Stockholm, Sweden
  • Olivier Lortholary, Paris, France
  • Joseph Meletiadis, Athens, Greece
  • Patricia Muñoz, Madrid, Spain
  • Livio Pagano, Rome, Italy
  • George Petrikkos, Athens, Greece
  • Juan Luis Rodriguez-Tudela, Majadahonda, Spain
  • Emmanuel Roilides, Thessaloniki, Greece
  • Helen Sabatakou, Athens, Greece
  • George Samonis, Heraklion, Greece
  • Anna Skiada, Athens, Greece
  • Sotirios Tsiodras, Athens, Greece
  • Paul Verweij, Nijmegen, The Netherlands
  • Georgia Vrioni, Athens, Greece
  • Theoklis Zaoutis, Philadelphia, PA, USA